Erratum: Associations between repeated measures of maternal urinary phthalate metabolites and thyroid hormone parameters during pregnancy (Environ Health Perspect, (2016) 124, 11, 10.1289/EHP170);Associations between repeated measures of maternal urinary phthalate metabolites and thyroid hormone parameters during pregnancy

Environmental Health Perspectives

Volumn 124, Issue 11, 2016, Pages 1808-1815

  Johns, Lauren E ^a   Ferguson, Kelly K ^a   McElrath, Thomas F ^b   Mukherjee, Bhramar ^a   Meeker, John D ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHTHALIC ACID; THYROID HORMONE; THYROTROPIN; PHTHALIC ACID DERIVATIVE;

ADULT; ARTICLE; CHEMOLUMINESCENCE; DRUG EXPOSURE; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HUMAN; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PUBLIC HEALTH; QUESTIONNAIRE; RADIOIMMUNOASSAY; TANDEM MASS SPECTROMETRY; BLOOD; CASE CONTROL STUDY; FETUS DEVELOPMENT; HOMEOSTASIS; METABOLISM; STATISTICAL MODEL; URINE;

ADULT; CASE-CONTROL STUDIES; FEMALE; FETAL DEVELOPMENT; HOMEOSTASIS; HUMANS; LINEAR MODELS; PHTHALIC ACIDS; PREGNANCY; THYROID HORMONES;

EID: 84994299996     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/EHP4856     Document Type: Erratum

References (63)

1. Adibi JJ, Perera FP, Jedrychowski W, Camann DE, Barr D, Jacek R, et al. 2003. Prenatal exposures to phthalates among women in New York City and Krakow, Poland. Environ Health Perspect 111:1719-1722, doi: 10.1289/ehp.6235.
2. Aggarawal N, Suri V, Singla R, Chopra S, Sikka P, Shah VN, et al. 2014. Pregnancy outcome in hyperthyroidism: a case control study. Gynecol Obstet Invest 77:94-99.
3. ATSDR (Agency for Toxic Substances and Disease Registry). 2001. Toxicological Profile for Di-n-butyl Phthalate. Atlanta, Georgia:ATSDR. Available: http://www.atsdr.cdc.gov/ToxProfiles/tp135.pdf [accessed 12 September 2016].
4. ATSDR. 2002. Toxicological Profile for Di(2-ethylhexyl) Phthalate. Atlanta, Georgia:ATSDR. Available: http://www.atsdr.cdc.gov/toxprofiles/tp9.pdf [accessed 12 September 2016].
5. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. 2005. Urinary creatinine concentrations in the U.S. population implications for urinary biologic monitoring measurements. Environ Health Perspect 113:192-200, doi: 10.1289/ehp.7337.
6. Boas M, Feldt-Rasmussen U, Main KM. 2012. Thyroid effects of endocrine disrupting chemicals. Mol Cell Endocrinol 355:240-248.
7. Boas M, Frederiksen H, Feldt-Rasmussen U, Skakkebæk NE, Hegedüs L, Hilsted L, et al. 2010. Childhood exposure to phthalates: associations with thyroid function, insulin-like growth factor I, and growth. Environ Health Perspect 118:1458-1464, doi: 10.1289/ehp.0901331.
8. Boas M, Main KM, Feldt-Rasmussen U. 2009. Environmental chemicals and thyroid function: an update. Curr Opin Endocrinol Diabetes Obes 16:385-391.
9. Breous E, Wenzel A, Loos U. 2005. The promoter of the human sodium/iodide symporter responds to certain phthalate plasticisers. Mol Cell Endocrinol 244:75-78.
10. Caldwell KL, Pan Y, Mortensen ME, Makhmudov A, Merrill L, Moye J. 2013. Iodine status in pregnant women in the National Children’s Study and in U.S. women (15-44 years), National Health and Nutrition Examination Survey 2005-2010. Thyroid 23:927-937.
11. Cantonwine DE, Cordero JF, Rivera-González LO, Anzalota Del Toro LV, Ferguson KK, Mukherjee B, et al. 2014. Urinary phthalate metabolite concentrations among pregnant women in Northern Puerto Rico: distribution, temporal variability, and predictors. Environ Int 62:1-11.
12. Casas L, Fernandez MF, Llop S, Guxens M, Ballester F, Olea N, et al. 2011. Urinary concentrations of phthalates and phenols in a population of Spanish pregnant women and children. Environ Int 37:858-866.
13. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, et al. 2005. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 105:239-245.
14. Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG. 2006. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 107(2 pt 1):337-341.
15. Chen LM, Du WJ, Dai J, Zhang Q, Si GX, Yang H, et al. 2014. Effects of subclinical hypothyroidism on maternal and perinatal outcomes during pregnancy: a single-center cohort study of a Chinese population. PLoS One 9:e109364, doi: 10.1371/journal.pone.0109364.
16. Dietrich JW, Landgrafe G, Fotiadou EH. 2012. TSH and thyrotropic agonists: key actors in thyroid homeostasis. J Thyroid Res 2012:351864, doi: 10.1155/2012/351864.
17. Ferguson KK, McElrath TF, Chen YH, Mukherjee B, Meeker JD. 2015. Urinary phthalate metabolites and biomarkers of oxidative stress in pregnant women: a repeated measures analysis. Environ Health Perspect 123:210-216, doi: 10.1289/ehp.1307996.
18. Ferguson KK, McElrath TF, Ko YA, Mukherjee B, Meeker JD. 2014a. Variability in urinary phthalate metabolite levels across pregnancy and sensitive windows of exposure for the risk of preterm birth. Environ Int 70:118-124.
19. Ferguson KK, McElrath TF, Meeker JD. 2014b. Environmental phthalate exposure and preterm birth. JAMA Pediatr 168:61-67.
20. Glinoer D, de Nayer P, Bourdoux P, Lemone M, Robyn C, van Steirteghem A, et al. 1990. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 71:276-287.
21. Hartoft-Nielsen ML, Boas M, Bliddal S, Rasmussen AK, Main K, Feldt-Rasmussen U. 2011. Do thyroid disrupting chemicals influence foetal development during pregnancy? J Thyroid Res 2011:342189, doi: 10.4061/2011/342189.
22. Hatch EE, Nelson JW, Qureshi MM, Weinberg J, Moore LL, Singer M, et al. 2008. Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health 7:27, doi: 10.1186/1476-069X-7-27.
23. Hornung RW, Reed LD. 1990. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 5:46-51.
24. Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC. 2007. Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod 22:2715-2722.
25. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. 2005. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf) 62:487-491.
26. IOM (Institute of Medicine Committee on Understanding Premature Birth and Assuring Healthy Outcomes), Behrman RE, Butler AS, eds. 2007. Preterm Birth: Causes, Consequences, and Prevention. Washington, DC:National Academies Press.
27. Ishihara A, Sawatsubashi S, Yamauchi K. 2003. Endocrine disrupting chemicals: interference of thyroid hormone binding to transthyretins and to thyroid hormone receptors. Mol Cell Endocrinol 199:105-117.
28. Johns LE, Ferguson KK, Soldin OP, Cantonwine DE, Rivera-González LO, Del Toro LV, et al. 2015. Urinary phthalate metabolites in relation to maternal serum thyroid and sex hormone levels during pregnancy: a longitudinal analysis. Reprod Biol Endocrinol 13:4, doi: 10.1186/1477-7827-13-4.
29. Kashiwagi K, Furuno N, Kitamura S, Ohta S, Sugihara K, Utsumi K, et al. 2009. Disruption of thyroid hormone function by environmental pollutants. J Health Sci 55:147-160.
30. Kuo FC, Su SW, Wu CF, Huang MC, Shiea J, Chen BH, et al. 2015. Relationship of urinary phthalate metabolites with serum thyroid hormones in pregnant women and their newborns: a prospective birth cohort in Taiwan. PLoS One 10:e0123884, doi: 10.1371/journal.pone.0123884.
31. Lee RH, Spencer CA, Mestman JH, Miller EA, Petrovic I, Braverman LE, et al. 2009. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol 200:260e1-260e6, doi: 10.1016/j.ajog.2008.10.042.
32. Lewis RC, Meeker JD, Peterson KE, Lee JM, Pace GG, Cantoral A, et al. 2013. Predictors of urinary bisphenol A and phthalate metabolite concentrations in Mexican children. Chemosphere 93:2390-2398.
33. Liu C, Zhao L, Wei L, Li L. 2015. DEHP reduces thyroid hormones via interacting with hormone synthesis-related proteins, deiodinases, transthyretin, receptors, and hepatic enzymes in rats. Environ Sci Pollut Res Int 22:12711-12719.
34. McElrath TF, Lim KH, Pare E, Rich-Edwards J, Pucci D, Troisi R, et al. 2012. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. Am J Obstet Gynecol 207:407e1-407e7, doi: 10.1016/j.ajog.2012.08.010.
35. Medici M, Timmermans S, Visser W, de Muinck Keizer-Schrama SM, Jaddoe VW, Hofman A, et al. 2013. Maternal thyroid hormone parameters during early pregnancy and birth weight: the Generation R Study. J Clin Endocrinol Metab 98:59-66.
36. Meeker JD, Calafat AM, Hauser R. 2007. Di(2-ethylhexyl) phthalate metabolites may alter thyroid hormone levels in men. Environ Health Perspect 115:1029-1034, doi: 10.1289/ehp.9852.
37. Meeker JD, Ferguson KK. 2011. Relationship between urinary phthalate and bisphenol A concentrations and serum thyroid measures in U.S. adults and adolescents from the National Health and Nutrition Examination Survey (NHANES) 2007-2008. Environ Health Perspect 119:1396-1402, doi: 10.1289/ehp.1103582.
38. Meeker JD, Hu H, Cantonwine DE, Lamadrid-Figueroa H, Calafat AM, Ettinger AS, et al. 2009. Urinary phthalate metabolites in relation to preterm birth in Mexico City. Environ Health Perspect 117:1587-1592, doi: 10.1289/ehp.0800522.
39. Mendez W Jr., Eftim SE. 2012. Biomarkers of perchlorate exposure are correlated with circulating thyroid hormone levels in the 2007-2008 NHANES. Environ Res 118:137-144.
40. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. 1994. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 84:946-949.
41. Mortoglou A, Candiloros H. 2004. The serum triiodothyronine to thyroxine (T3/T4) ratio in various thyroid disorders and after Levothyroxine replacement therapy. Hormones (Athens) 3:120-126.
42. Nelson JC, Weiss RM, Wilcox RB. 1994. Underestimates of serum free thyroxine (T4) concentrations by free T4 immunoassays. J Clin Endocrinol Metab 79:76-79.
43. Obregon MJ, Calvo RM, Del Rey FE, de Escobar GM. 2007. Ontogenesis of thyroid function and interactions with maternal function. Endocr Dev 10:86-98.
44. Peeters RP. 2008. Thyroid hormones and aging. Hormones (Athens) 7:28-35.
45. Perneger TV. 1998. What’s wrong with Bonferroni adjustments. BMJ 316:1236-1238.
46. Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, Vannasaeng S, Nitiyanant W, Boonnamsiri V, et al. 2001. Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol (Oxf) 54:365-370.
47. Préau L, Fini JB, Morvan-Dubois G, Demeneix B. 2015. Thyroid hormone signaling during early neurogenesis and its significance as a vulnerable window for endocrine disruption. Biochim Biophys Acta 1849:112-121.
48. Richardson DB, Rzehak P, Klenk J, Weiland SK. 2007. Analyses of case-control data for additional outcomes. Epidemiology 18:441-445.
49. Saki F, Dabbaghmanesh MH, Ghaemi SZ, Forouhari S, Ranjbar Omrani G, Bakhshayeshkaram M. 2014. Thyroid function in pregnancy and its influences on maternal and fetal outcomes. Int J Endocrinol Metab 12:e19378, doi: 10.5812/ijem.19378.
50. Schug TT, Janesick A, Blumberg B, Heindel JJ. 2011. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 127:204-215.
51. Shen O, Du G, Sun H, Wu W, Jiang Y, Song L, et al. 2009. Comparison of in vitro hormone activities of selected phthalates using reporter gene assays. Toxicol Lett 191:9-14.
52. Silva MJ, Samandar E, Preau JL Jr., Reidy JA, Needham LL, Calafat AM. 2007. Quantification of 22 phthalate metabolites in human urine. J Chromatogr B Analyt Technol Biomed Life Sci 860:106-112.
53. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. 2011. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21:1081-1125.
54. Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF. 1990. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 264:1422-1425.
55. Su PY, Huang K, Hao JH, Xu YQ, Yan SQ, Li T, et al. 2011. Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab 96:3234-3241.
56. Sugiyama S, Shimada N, Miyoshi H, Yamauchi K. 2005. Detection of thyroid system-disrupting chemicals using in vitro and in vivo screening assays in Xenopus laevis. Toxicol Sci 88:367-374.
57. Wang W, Teng W, Shan Z, Wang S, Li J, Zhu L, et al. 2011. The prevalence of thyroid disorders during early pregnancy in China: the benefits of universal screening in the first trimester of pregnancy. Eur J Endocrinol 164:263-268.
58. Wenzel A, Franz C, Breous E, Loos U. 2005. Modulation of iodide uptake by dialkyl phthalate plasticisers in FRTL-5 rat thyroid follicular cells. Mol Cell Endocrinol 244:63-71.
59. Williams GR. 2008. Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol 20:784-794.
60. Zhai W, Huang Z, Chen L, Feng C, Li B, Li T. 2014. Thyroid endocrine disruption in zebrafish larvae after exposure to mono-(2-ethylhexyl) phthalate (MEHP). PLoS One 9:e92465, doi: 10.1371/journal.pone.0092465.
61. Zimmermann MB, Köhrle J. 2002. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid 12:867-878.
62. Zoeller RT. 2005. Environmental chemicals as thyroid hormone analogues: new studies indicate that thyroid hormone receptors are targets of industrial chemicals? Mol Cell Endocrinol 242:10-15.
63. Zoeller RT. 2007. Environmental chemicals impacting the thyroid: targets and consequences. Thyroid 17:811-817.